SAN JOSE, Calif., Nov. 12 /PRNewswire-FirstCall/ --VNUS(R) Medical Technologies, Inc. , a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the Lazard Capital Markets 5th Annual Healthcare Conference, to be held November 18-19, 2008, at the St. Regis Hotel in New York City.
VNUS’ presentation is currently scheduled for 3:30 p.m. ET on Wednesday, November 19, and will be webcast on the corporate website at http://ir.vnus.com/events.cfm. The management speaker will be Brian Farley, President and Chief Executive Officer.
About VNUS Medical Technologies, Inc.
VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux, a progressive condition caused by incompetent vein valves in the leg. VNUS sells the Closure system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to treat diseased veins through the application of temperature-controlled RF energy. For more information, please visit the corporate website at http://www.vnus.com.
CONTACT: Peter Osborne, Chief Financial Officer and Vice President of
Finance and Administration of VNUS Medical Technologies, Inc.,
+1-408-360-7499, ir@vnus.com
Web site: http://www.vnus.com/
